key: cord-1052918-ux5wjonx
authors: Temgoua, Mazou Ngou; Kuaté, Liliane Mfeukeu; Ngatchou, William; Sibetcheu, Aurelie; Toupendi, Zouliatou Nzina; Belobo, Grace; Ossa, Alice; Kingue, Samuel
title: Thromboembolic risks in patients with COVID-19: major concern to consider in our management
date: 2020-04-27
journal: Pan Afr Med J
DOI: 10.11604/pamj.2020.35.2.22945
sha: 85107565107696fb07039682b3e01d15bf4f6e87
doc_id: 1052918
cord_uid: ux5wjonx

COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce mortality in these patients.

Recently the role of thromboembolic events has been suspected. In a study done by Cui et al. who enrolled 81 patients in Intensive Care Unit (ICU) in China, the incidence of venous thromboembolism (VTE) in these patients was 25% with a death rate of 9.8% [4] . Klok et al. found almost the same incidence in Holland, in a total of 184 patients admitted in ICU, 27% developed thromboembolic complications [5] . The potential mechanisms associated with thromboembolism in COVID-19 could be excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation [5] . The risk may be enhanced in patients with known thromboembolic risk factors like old age, obesity, cancer, pregnancy and could partially explain the susceptibility of death in this population [3] . Tang et al. in China also found that high levels of D-dimers were linked to poor prognosis of patients and that prophylactic use of heparin for at least 7 days significantly reduced death [6] . Patients with COVID-19 can rapidely develop severe complications such as renal and pulmonary failure, liver dysfunction which can affect both VTE and bleeding status [2, 7] .

Since COVID-19 patients with high risk of VTE had poor outcomes compared to those with low risk, the thromboembolism risk should be accurately evaluated [8] . Many comprehensive scores such as Caprini, Padua had been proposed for the VTE and bleeding risk assesment in various clinical settings [7] [8] [9] . Given the increase risk of thromboembolism in COVID-19 patients particularly those in ICU, it is important to implement prophylactic use of anticoagulation and/or mechanical compression stockings in order to prevent death of these patients. Unfortunately, a recent study in China showed that this recommandation is not always respected [8] . It should also be noted that there is a corresponding increase in the risk of bleeding due to the sepsis in these patients. Tang et al. found that COVID-19 patients who died in ICU have longer prothrombin time and activated partial thromboplastin time [10] . So it is also very important to assess the risk of bleeding in patients before the use of anticoagulation.

Thromboembolism is highly prevalent in COVID-19 patients and contributes as an important cause of death. Prophylactic measures to prevent it's incidence should be implemented in all protocols however bearing in mind the risk of bleeding.

WHO. Coronavirus disease 2019 (COVID-19) Situation Report -55. 2020. Accessed on

Clinical characteristics of coronavirus disease 2019 in China

Estimates of the severity of coronavirus disease 2019: a modelbased analysis. The Lancet Infectious Diseases

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. The Lancet Haematology

A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score

Venous thromboembolism prophylaxis using the Caprini score. Disease-a-Month

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

The authors declare no competing interests.

Study conception: MNT, LMK, WN; mansucript writing: MNT; critical revision: AS, NTZ, GB, AO; supervision: SK. All the authors have read and agreed to the final manuscript.